$327.99−$27.49 (-7.73%)as of market close, Jul 24, 2026
WST — West Pharmaceutical Services Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $327.99
- Change YTD
- +18.67%
- Market cap
- 23.1B
- Enterprise value
- 22.8B
- Shares outstanding
- 70.4M
- 52W low
- $223.83
- 52W high
- $386.00
- From 52W high
- -15.03%
- From 52W low
- +46.54%
- 52W range
- 64%
- Beta
- 1.16
Volume
- Rel volume
- 2.52×
- 30D volume
- 815.3K
- 30D $ vol
- 282.5M
Fundamentals
- Sales (ttm)
- 3.3B
- Sales/share
- $47.27
- EPS (ttm)
- $7.92
- FCF (ttm)
- 436.9M
- FCF/share
- $6.21
- Book value/share
- $42.49
- Net margin
- 16.98%
- ROE
- 18.89%
- ROA
- 13.86%
- Debt / equity
- 0.07×
- Current ratio
- 2.82
Growth (CAGR, ttm) · 10Y
- Sales
- +8.63%
- Net income
- +18.71%
- FCF
- +20.54%
- Shares
- -0.40%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +19.28%
- Sales/share
- +9.06%
- FCF/share
- +21.01%
- Book value/share
- +10.86%
- Dividend/share
- +6.35%
- Price
- +15.44%
- Total return
- +15.85%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 40.9×
- Fwd P/E
- 37.3×
- P/S (ttm)
- 6.9×
- P/B (mrq)
- 7.7×
- P/FCF (ttm)
- 52.8×
- EV/EBITDA (fy)
- 30.2×
- EV/Sales (ttm)
- 6.9×
- FCF yield (ttm)
- 1.89%
- Dividend yield (fwd)
- 0.27%
- Dividend/share (fwd)
- $0.88
- Buyback yield (ttm)
- 1.97%
- Shareholder yield (ttm)
- 2.24%
Vs own 10Y history
- P/E
- 35th
- P/S
- 54th
- P/B
- 54th
- P/FCF
- 37th
Bar = where today's multiple sits in WST's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
-7.73%
1W
-8.44%
1M
-3.65%
3M
+5.91%
YTD
+18.67%
1Y
+44.29%
5Y
-12.22%
Financial statements
Open full WST financials →Related Healthcare
1MWest Pharmaceutical Services Inc. (WST) trades at $327.99 with a live price and an interactive chart covering 45+ years of daily price history, plus key valuation metrics. ChartRow also publishes WST's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full WST financial statements →